Skip to main content
OpenTrials

Clinical trial condition

Ocular Hypertension

Explore clinical trials studying Ocular Hypertension. Study availability and eligibility vary by location and protocol.

440 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Ocular Hypertension trial results

Completed

A Study of Glaucoma or Ocular Hypertension in Patients Within the United States

NCT00800267

Conditions
Eye Diseases, Glaucoma, Ocular Hypertension
Locations
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Sacramento, California, United States
  • Pfizer Investigational Site Sacramento, California, United States
View all 53 locations
View Trial Details
Completed

Long-Term Non-Interventional Latanoprost Study

NCT01265719

Conditions
Eye Diseases, Glaucoma, Ocular Hypertension
Locations
  • Universitair Ziekenhuis Antwerpen, Dienst Oftalmologie Edegem, Belgium
  • Universitair Ziekenhuis Leuven - Campus Sint-Raphaël Leuven, Belgium
  • Clinica de Oftalmologia San Diego Medellín, Antioquia, Colombia
  • Fakultni nemocnice Brno Brno, Czechia
View all 29 locations
View Trial Details
Completed

A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

NCT00647101

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
Locations
  • Pfizer Investigational Site Albi, France
  • Pfizer Investigational Site Ambert, France
  • Pfizer Investigational Site Amboise, France
  • Pfizer Investigational Site Angers, France
View all 176 locations
View Trial Details
Completed

A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

NCT00638742

Conditions
Eye Diseases, Glaucoma, Ocular Hypertension
Locations
  • Pfizer Investigational Site Artesia, California, United States
  • Pfizer Investigational Site Atlanta, Georgia, United States
  • Pfizer Investigational Site Atlanta, Georgia, United States
  • Pfizer Investigational Site North Dartmouth, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

NCT01379144

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • Eye Associates Pty Limited Sydney, New South Wales, Australia
  • Save Sight Institute Sydney, New South Wales, Australia
  • Royal Adelaide Hospital, North Terrace Adelaide, South Australia, Australia
  • University Hospital Brno-Bohunice Brno, Czechia
View all 25 locations
View Trial Details

Related conditions